IFOSFAMIDE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 130 adverse event reports in the FDA FAERS database where IFOSFAMIDE was used for Neoplasm malignant.
Most Reported Side Effects for IFOSFAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,281 | 13.4% | 486 | 629 |
| Febrile neutropenia | 2,225 | 13.1% | 228 | 1,165 |
| Disease progression | 1,912 | 11.2% | 515 | 198 |
| Neutropenia | 1,509 | 8.9% | 173 | 417 |
| Drug ineffective | 1,331 | 7.8% | 416 | 317 |
| Thrombocytopenia | 1,227 | 7.2% | 140 | 317 |
| Anaemia | 1,067 | 6.3% | 94 | 365 |
| Product use in unapproved indication | 890 | 5.2% | 190 | 183 |
| Pyrexia | 752 | 4.4% | 107 | 493 |
| Sepsis | 712 | 4.2% | 406 | 273 |
| Malignant neoplasm progression | 671 | 4.0% | 210 | 120 |
| Infection | 649 | 3.8% | 177 | 113 |
| Pancytopenia | 632 | 3.7% | 144 | 270 |
| Encephalopathy | 585 | 3.4% | 72 | 287 |
| Vomiting | 570 | 3.4% | 80 | 274 |
Other Indications for IFOSFAMIDE
Diffuse large b-cell lymphoma (2,425)
Ewing's sarcoma (937)
Product used for unknown indication (910)
Osteosarcoma (845)
B-cell lymphoma (541)
Hodgkin's disease (533)
Burkitt's lymphoma (472)
Non-hodgkin's lymphoma (434)
Chemotherapy (429)
Central nervous system lymphoma (394)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)